Brief: Geneuro Cash Position 16.5 Million Euros At 31 December
Jan 29 (Reuters) - GENEURO SA GNRO.PA :
* SOLID CASH POSITION OF EUR 16.5 MILLION, INCLUDING EUR 7.5
MILLION CREDIT FACILITY AT 31 DECEMBER
* POSITIVE 6 MONTHS RESULTS FROM TEMELIMAB PHASE 2A TRIAL IN
ADULT
TYPE 1 DIABETES (T1D) PATIENTS
* ONGOING PRECLINICAL DEVELOPMENT OF A NEW ANTIBODY AGAINST
AMYOTROPHIC LATERAL SCLEROSIS, AIMING TO REACH CLINIC IN 2020
Source text for Eikon: urn:newsml:reuters.com:*:nBw7wGrbva
Further company coverage: GNRO.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement